Orbis Allan Gray LTD Genmab A/S Transaction History
Orbis Allan Gray LTD
- $14.8 Billion
- Q4 2024
A detailed history of Orbis Allan Gray LTD transactions in Genmab A/S stock. As of the latest transaction made, Orbis Allan Gray LTD holds 2,815,562 shares of GMAB stock, worth $60 Million. This represents 0.4% of its overall portfolio holdings.
Number of Shares
2,815,562
Previous 1,676,793
67.91%
Holding current value
$60 Million
Previous $40.9 Million
43.74%
% of portfolio
0.4%
Previous 0.26%
Shares
2 transactions
Others Institutions Holding GMAB
# of Institutions
236Shares Held
56.3MCall Options Held
25.3KPut Options Held
33.4K-
Alliancebernstein L.P. New York, NY14.9MShares$318 Million0.11% of portfolio
-
Black Rock Inc. New York, NY5.08MShares$108 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.09MShares$65.9 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.81MShares$59.8 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA2.57MShares$54.8 Million0.01% of portfolio
About GENMAB A/S
- Ticker GMAB
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 658,292,992
- Market Cap $14B
- Description
- Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...